Mangatal J
IN THE GRAND COURT OF THE C
JUDGMENT Introduction 1
22 September 2017
In accordance with the Directions
Indeed, the Second Variation
This valuation technique determines fair value by calculating
16.3. In the Pharma
Obviously, if for example a contract was
the acceptable range of disclosable calendar
a. Cost Approach The Cost Approach
financial projections and informed by historical financials
during the prior five years, other companies
years would be required as a basis for
well-established company, given the rapidity
shareholders in some other cases have been
Resolution
It is noteworthy
absence of any evidence that Dr.